Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients.

Journal of gastroenterology and hepatology - 1 Feb 1997

Kuwana K, Ichida T, Kamimura T, Ohkoshi S, Ogata N, Harada T, Endoh K, Asakura H

Abstract excerpt

The aims of the present study were to clarify the risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis C virus (HCV) infection and to investigate the effectiveness of interferon (IFN) therapy. We retrospectively studied 343 patients who had been admitted to our hospital; 161 with chronic hepatitis, 49 with liver cirrhosis, 42 with chronic hepatitis bearing HCC and 91 with liver...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C

Share to Liver Neoplasms

Share to Risk Factors

Share to RNA, Viral

Source

Identifiers

PMID: 9083916
DOI: 10.1111/j.1440-1746.1997.tb00398.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients.PMID 9083916Read ↗

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.Semantic proximity Read ↗

Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis.Semantic proximity Read ↗

Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype.Semantic proximity Read ↗

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study.Semantic proximity Read ↗

Risk of hepatocellular carcinoma development in cases of hepatitis C treated by long-term, low-dose PEG-IFNα-2a.Semantic proximity Read ↗

Hepatitis C virus-induced hepatocellular carcinoma: a narrative review.Semantic proximity Read ↗

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.Semantic proximity Read ↗

A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis.Semantic proximity Read ↗

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.Semantic proximity Read ↗

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.Semantic proximity Read ↗

Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B.Semantic proximity Read ↗

Hepatitis C virus genotypes and the development of hepatocellular carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.